BLUE Jan 2026 0.500 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:59PM EDT. Market open.
| Previous close | 0.8000 |
| Open | 0.8000 |
| Bid | 0.6000 |
| Ask | 1.0000 |
| Strike | 0.50 |
| Expiry date | 2026-01-16 |
| Day's range | 0.8000 - 0.8000 |
| Contract range | N/A |
| Volume | |
| Open interest | 1.01k |
PR Newswire2Flo Ventures Announces Addition of Renowned Life Sciences Executive Charlotte Jones-Burton, MD, MS as a Partner
2Flo Ventures, an emerging venture capital firm and startup studio focused on the discovery, development, and commercialization of healthcare solutions that address disparities in outcomes and health equity broadly, is pleased to announce the addition of Dr. Charlotte Jones-Burton as a Partner and Head of Life Science Product Development and Strategy.
Business Wirebluebird bio Appoints O. James Sterling as Chief Financial Officer
SOMERVILLE, Mass., May 29, 2024--bluebird bio, Inc. (Nasdaq: BLUE) today announced that O. James Sterling, has been appointed chief financial officer (CFO), effective June 10, 2024. Mr. Sterling most recently served as chief financial officer of Renalytix plc, a diagnostics company focused on clinical management of kidney disease.
- GuruFocus.com
bluebird bio Inc (BLUE) Q1 2024 Earnings: Surpasses Revenue Expectations with Strategic Focus ...
Detailed Analysis of Financial Performance and Future Outlook
© 2024 Yahoo. All rights reserved.